Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material

• Zhuochun Peng,

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Chundsell Medicals AB, Stockholm, Sweden

  ⨯
• Karl Andersson,

  Affiliations Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, Ridgeview Instruments AB, Uppsala, Sweden

  ⨯
• Johan Lindholm,

  Affiliation Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Olga Dethlefsen,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Setia Pramana,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Yudi Pawitan,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Monica Nistér,

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Clinical Pathology/Cytology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Sten Nilsson,

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Clinical Oncology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Chunde Li

  * E-mail: Chunde.li@ki.se

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Clinical Oncology, Karolinska University Hospital, Stockholm, Sweden, Chundsell Medicals AB, Stockholm, Sweden

  ⨯